000288987 001__ 288987
000288987 005__ 20250825133607.0
000288987 0247_ $$2doi$$a10.1016/j.antiviral.2024.105856
000288987 0247_ $$2ISSN$$a0166-3542
000288987 0247_ $$2ISSN$$a1872-9096
000288987 0247_ $$2altmetric$$aaltmetric:160425078
000288987 0247_ $$2pmid$$apmid:38447646
000288987 037__ $$aDKFZ-2024-00534
000288987 082__ $$a610
000288987 1001_ $$00000-0002-4041-6102$$aKlevanski, Maja$$b0
000288987 245__ $$aGlycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin A
000288987 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2024
000288987 3367_ $$2DRIVER$$aarticle
000288987 3367_ $$2DataCite$$aOutput Types/Journal article
000288987 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1713534806_15505
000288987 3367_ $$2BibTeX$$aARTICLE
000288987 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000288987 3367_ $$00$$2EndNote$$aJournal Article
000288987 500__ $$a#LA:F170# /NEU/#LA:D430# / 2024 May;225:105856
000288987 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000288987 588__ $$aDataset connected to CrossRef, Journals: inrepo02.dkfz.de
000288987 7001_ $$aKim, Heeyoung$$b1
000288987 7001_ $$aHeilemann, Mike$$b2
000288987 7001_ $$aKuner, Thomas$$b3
000288987 7001_ $$0P:(DE-He78)1d3968d2f0ff3eae55f6b2ea4c474387$$aBartenschlager, Ralf$$b4$$eLast author$$udkfz
000288987 773__ $$0PERI:(DE-600)1495861-2$$a10.1016/j.antiviral.2024.105856$$gVol. 225, p. 105856 -$$p105856$$tAntiviral research$$v225$$x0166-3542$$y2024
000288987 8564_ $$uhttps://inrepo02.dkfz.de/record/288987/files/1-s2.0-S0166354224000640-main.pdf
000288987 8564_ $$uhttps://inrepo02.dkfz.de/record/288987/files/1-s2.0-S0166354224000640-main.pdf?subformat=pdfa$$xpdfa
000288987 909CO $$ooai:inrepo02.dkfz.de:288987$$pVDB
000288987 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1d3968d2f0ff3eae55f6b2ea4c474387$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000288987 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000288987 9141_ $$y2024
000288987 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-08-19$$wger
000288987 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bANTIVIR RES : 2022$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-19
000288987 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bANTIVIR RES : 2022$$d2023-08-19
000288987 9202_ $$0I:(DE-He78)F170-20160331$$kF170$$lVirus-assoziierte Karzinogenese$$x0
000288987 9201_ $$0I:(DE-He78)F170-20160331$$kF170$$lVirus-assoziierte Karzinogenese$$x0
000288987 9201_ $$0I:(DE-He78)D430-20160331$$kD430$$lVirus-assoziierte Karzinogenese$$x1
000288987 980__ $$ajournal
000288987 980__ $$aVDB
000288987 980__ $$aI:(DE-He78)F170-20160331
000288987 980__ $$aI:(DE-He78)D430-20160331
000288987 980__ $$aUNRESTRICTED